FREMONT, Calif., June 13 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) today announced that the company will participate in the upcoming William Blair 27th Annual Growth Stock Conference in Chicago on Thursday, June 21, 2007, at 3:50 p.m. Central time.
The live webcast of the presentation will be available through the PDL website: http://www.pdl.com. Please connect to this website at least 15 minutes prior to the live webcast to allow time for any software download that may be needed to hear the webcast. A replay will be available at http://www.pdl.com starting approximately one hour after completion of the webcast.
About PDL BioPharma
PDL BioPharma, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for severe or life-threatening illnesses. Commercially focused in the acute-care hospital setting, PDL markets and sells its portfolio of commercial products in the United States and Canada. A pioneer of antibody humanization technology, PDL promotes this technology through licensing agreements and clinical development of its own diverse pipeline of investigational compounds. PDL’s research platform centers on the discovery and development of antibodies to treat cancer and autoimmune diseases. For more information, please visit http://www.pdl.com.
NOTE: PDL BioPharma and the PDL logo are considered trademarks of PDL BioPharma, Inc.
PDL BioPharma, Inc.
CONTACT: Ami Knoefler, Corporate and Investor Relations, +1-510-284-8851,ami.knoefler@pdl.com, or Jean Suzuki, Investor Relations, +1-510-574-1550,jean.suzuki@pdl.com, both of PDL BioPharma, Inc.
Web site: http://www.pdl.com/
